This human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate is approved for the treatment of patients with HER2-positive, metastatic breast cancer.
Sarah Peters
Advertisement
Articles by Sarah Peters
Advertisement
Latest Updated Articles
- Ado-trastuzumab Emtansine (Kadcyla)
Published: July 22nd 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
TACTI-004 Trial Studying Eftilagimod Alfa With Pembrolizumab in Advanced NSCLC to Begin Evaluation
3
UConn’s Medical Writing Certificate Program: It’s Just "Write"
4
Pharmacy Policy Updates for October 2025
5
